2011 Media Kit

Reaching oncology and hematology professionals with an integrated multimedia approach — delivering the news how they want it, when they want it.

Print and digital (www.ASCOPost.com, mobile and e-newsletters)

2D Barcode Technology

EditorialThe ASCO Post features highly validated coverage of

• Need-to-know cancer research

• Health policy news

• Clinical practice issues

• Thoughtful commentary from oncology opinion leaders and ASCO members

Led by Editor-in-Chief, James O. Armitage, MD, University of Nebraska Medical Center, Former President of ASCO. Dr. Armitage is an internationally renowned hematologist-oncologist with expertise in bone marrow transplantation and the management and classification of lymphoma and leukemia.

About the American Society of Clinical Oncology• A nonprofit organization founded in 1964 with the overarching goals of improving cancer care and prevention.

• More than 28,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties.

• Members include physicians and health-care professionals in all levels of the practice of oncology.

CirculationThe ASCO Post is intended for every professional with an interest in oncology. As a benefit of membership, the print edition is distributed to all US-based ASCO members. In addition, the universe of non–ASCO member medical oncologists, hematologists, hematologists/oncologists, gynecologic oncologists, surgical oncologists, and musculoskeletal oncologists receive the publication on a complimentary basis. There are also 1,300 member radiation oncologists included. In addition, over 2,000 oncology nurse practitioners receive the publication.

Breakdown by Specialty AreaHematologists/Oncologists 6,164

Medical Oncologists 5,127

Oncology Nurse Practitioners 2,038

Hematologists 2,026

Radiation Oncologists 1,374

Gynecologic Oncologists 649

Surgical Oncologists 361

Musculoskeletal Oncologists 77

Other ASCO Members* 8,571

Total 26,387

ASCO Member Profile: Board Certification of US-based ASCO MembersMedical Oncology 8,690

Internal Medicine 2,147

Radiation Oncology 1,374

Surgery (Surgical Oncology and Specialties) 1,032

Pediatrics (Pediatric Oncology and Specialties) 779

Hematology 720

Gynecologic Oncology 374

Oncology Nurse 248

Oncology Pharmacy 112

* Includes: pediatric oncologists (777); surgery and surgical subspecialties (862); internal medicine specialists (2,144); oncology pharmacists (112); and others, including lab personnel, pathologists, biostatisticians, urologists, allied health-care professionals, physician assistants, nurses, etc.

James O. Armitage, MD

Readership and Reader Perception Feedback Study ResultsA study was conducted by The Matalia Group to measure readership, reader satisfaction levels, and audience perception of The ASCO Post after only 3 issues were mailed. The study was conducted primarily by direct mail among a sample of 1,200 Hematologists/Oncologists and Medical Oncologists from a random sample from the AMA list. The blinded study included a check for $10 as an incentive. After 4 weeks, the study had a 19.5% response rate.

Readership – The ASCO Post  ranked 3rd among the 8 oncology newspapers and reached 50%.

Perception – Readers viewed The ASCO Post as significantly more relevant, comprehensive, substantive, and credible than the top three competing oncology newspapers.

Satisfaction levels – Using paired comparisons, readers indicated that The ASCO Post offered a better return on investment of their reading time than the top three competing oncology publications.

Distinctive quality – Readers picked The ASCO Post as the most distinctive oncology tabloid, largely because of its affiliation with ASCO.

2D barcode use value – 30% of the readers considered  the use of the 2D barcode throughout the publication to be valuable, while 46% had not yet tried it, and 18% did not yet own a smartphone.

Format preference – 61% prefer to read The ASCO Post in print format only, and 27% prefer both print and online formats.

2011 Media Kit

Bonus Distribution at MeetingsIssue

2011 Gastrointestinal Cancers Symposium January 1, 2011

2011 Genitourinary Cancers Symposium February 15, 2011

National Comprehensive Cancer Network (NCCN) Annual Conference March 1, 2011

Oncology Nursing Society (ONS) Annual Congress April 15, 2011

American Society of Clinical Oncology (ASCO) Annual Meeting May 15, 2011

2011 Breast Cancer Symposium September 1, 2011

Oncology Nursing Society Institutes of Learning October 15, 2011

Chemotherapy Foundation Symposium November 1, 2011

American Society of Hematology (ASH) Annual Meeting November 15, 2011

San Antonio Breast Cancer Symposium November 15, 2011

0 10 20 30 40 50 60 70 80 90 100

Jrl MCC

Onc Rep

Onc&Biot News

Hem Onc Today

Onc News Int'l

Clin Onc News

The ASCO Post

Onc Times

6.8%

16.2%

17.5%

77.8%

21.4%

47.4%

50.0%

67.1%

0

Perc

ent o

f res

pond

ents

Publ

icat

ion

Percent read or scanned at least once in the last 3 months

Readership: The ASCO Post ranked #3 after only 3 issues

The ASCO Post delivers better ROI time than competition

10

20

30

40

50

Oncology Times

The ASCO Post

HemOnc Today

Clin Oncol News

0 10 20 30 40 50 60 70 80 90 100

Jrl MCC

Onc Rep

Onc&Biot News

Hem Onc Today

Onc News Int'l

Clin Onc News

The ASCO Post

Onc Times

6.8%

16.2%

17.5%

77.8%

21.4%

47.4%

50.0%

67.1%

0

Perc

ent o

f res

pond

ents

Publ

icat

ion

Percent read or scanned at least once in the last 3 months

Readership: The ASCO Post ranked #3 after only 3 issues

The ASCO Post delivers better ROI time than competition

10

20

30

40

50

Oncology Times

The ASCO Post

HemOnc Today

Clin Oncol News

Source: "Readership and Reader Perception-The ASCO Post," conducted by The Matalia Group, September 2010.

Harborside Press, LLC 37 Main Street

Cold Spring Harbor, New York 11724 Tel: (631) 692-0800 Fax: (631) 692-0805

www.harborsidepress.com

Advertiser Discount Programs with JCO and JOPEARNED FREQUENCY COMBINATION DISCOUNT Advertisers in Journal of Clinical Oncology ( JCO) or Journal of Oncology Practice ( JOP) who advertise in The ASCO Post will earn a frequency rate in The ASCO Post equal to that of the journal with the higher earned frequency.

MATCHING PAGE DISCOUNT Each individual product advertising in JCO or JOP during the same month it advertises in The ASCO Post will receive a $500 per page discount in The ASCO Post. Discount is based on the matching number of pages in The ASCO Post and JCO or JOP in a given month.

Challenges to NCI-SupportedCooperative Group Clinical TrialParticipation: An ASCO Survey ofCooperative Group Sites

By Allison R. Baer, RN, BSN, et al

Baer et al conclude that inadequate NCI per-case reimbursementis negatively affecting participation in cooperative trials, despite anexpressed preference for conducting NCI-approved and -fundedtrials. To improve participation and speed accrual, they suggest aprovision for reimbursement that compensates for the actual cost ofconducting these important studies. As Robin Zon, MD, FACP,notes in her accompanying commentary, the cooperative groupper-case reimbursement of $2,000 has not increased in 10 years.Published data from the 2005 ASCO and C-Change studies indicatethat during this same time period, the average cost per enrollee was$5,000 to $6,000, a discrepancy that is difficult to ignore.

Statewide Cancer Clinical TrialNavigation Service

By Karen Moffitt, PhD, et al

Importance of Testing forUsability When Selectingand Implementingan EHR/EMR System

By Natalie J. Corrao, MLIS, et al

Description of Current Practices ofEmpiric Chemotherapy DoseAdjustment in Obese Adult Patients

By Lisa A. Thompson, PharmD, et al

Daily Life As an AustralianMedical Oncologist

By Diana Adams, BSc(Hons), BMBCh(Oxon),MRCP, AMEC, FRACP, et al

Journal of Oncology Practice

now available on PubMed Central

A m e r i c a n S o c i e t y o f C l i n i c a l O n c o l o g y

Journal ofOncology

PracticeT H E A U T H O R I T A T I V E R E S O U R C E F O R O N C O L O G Y P R A C T I C E S

V O L U M E 6 I S S U E 3 M A Y 2010

http://jop.ascopubs.org

Vol 28, No 16 June 1, 2010

OURNAL OFLINICALNCOLOGY

Official Journal of the American Society of Clinical Oncology www.jco.org

JCO

JCO

Statin Use and Risk of Prostate Cancer Recurrence in Men Treated WithRadiation Therapy. R. Gutt et al. Editorial: A.V. D’Amico

Cytogenetics of Childhood Acute Myeloid Leukemia: United Kingdom MedicalResearch Council Treatment Trials AML 10 and 12. C.J. Harrison et al

Estrogen Alone in Postmenopausal Women and Breast Cancer Detection byMeans of Mammography and Breast Biopsy. R.T. Chlebowski et al

Phase I/IIa Study of Cilengitide and Temozolomide With ConcomitantRadiotherapy Followed by Cilengitide and Temozolomide MaintenanceTherapy in Patients With Newly Diagnosed Glioblastoma. R. Stupp et al

C-Reactive Protein and Risk of Lung Cancer. A.K. Chaturvedi et al

Intensity-Modulated Chemoradiotherapy Aiming to Reduce Dysphagia inPatients With Oropharyngeal Cancer: Clinical and Functional ResultsF.Y. Feng et al

Oral Clofarabine in the Treatment of Patients With Higher-RiskMyelodysplastic Syndrome. S. Faderl et al

Review Article: Coprescription of Tamoxifen and Medications That InhibitCYP2D6. K. Sideras et al

Biology of Neoplasia: Future of Personalized Medicine in Oncology: A SystemsBiology Approach. A.M. Gonzalez-Angulo et al

ASCO Special Article: ASCO/College of American Pathologists GuidelineRecommendations for Immunohistochemical Testing of Estrogen andProgesterone Receptors in Breast Cancer. M.E.H. Hammond et al

Other Advertising OpportunitiesE-TOC –The ASCO Post

• Highlights 6-8 articles from each issue with a direct link to the article on www.ASCOPost.com

• Reaches over 19,070 US-based ASCO members and 8,474 international members for a total reach of 27,544 (domestic list only is also available)

• Issued one week before printed issue mails

• Up to 3 ad sponsors per E-TOC (full banner, wide skyscraper, and button ads available)

Website advertising on www.ASCOPost.com

• Leaderboard, skyscraper, and medium rectangle ads available

Supplements

• Best of ASCO®

• Other specialty meetings available (Gastrointestinal Cancers Symposium, Genitourinary Cancers Symposium, Breast Cancer Symposium)

Digital Edition – Zmags ad upgrades available

NEW IN 2011: CONTINUITY PROGRAM

• Each individual brand advertising in 10 non-consecutive issues will receive 2 free ads of the same size for the brand.

• Each individual brand advertising in 15 issues will receive 3 free ads of the same size for the brand.